|
|
|
|
| | | | |
| | | | | |
organism-gene
|
|
PR:P36940 tumor necrosis factor ligand superfamily member 6 (rat) | rFASLG |
|
|
|
|
|
|
| | | | |
| | | | | |
organism-gene
|
|
PR:P41047 tumor necrosis factor ligand superfamily member 6 (mouse) | mFASLG |
|
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P41047-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) | mFASLG/iso:FasL |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | mFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P41047-2 tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) | mFASLG/iso:FasLS |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
organism-gene
|
|
PR:P48023 tumor necrosis factor ligand superfamily member 6 (human) | hFASLG |
|
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P48023-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (human) | hFASLG/iso:FasL |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | hFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | hFASLG/iso:FasL/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | hFASLG/iso:FasL/Clv:soluble |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P48023-2 tumor necrosis factor ligand superfamily member 6 isoform h2 (human) | hFASLG/iso:h2 |
|
|
|
|
|
|
| | | | |
| | | | | |
sequence
|
|
PR:000000276 tumor necrosis factor ligand superfamily member 6 isoform FasL | FASLG/iso:FasL |
|
|
|
|
|
|
| | | | | | |
| | | |
sequence
|
|
PR:000000278 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L | FASLG/iso:FasL/var:F273L |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | hFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | mFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P41047-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) | mFASLG/iso:FasL |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036783 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | mFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P48023-1 tumor necrosis factor ligand superfamily member 6 isoform FasL (human) | hFASLG/iso:FasL |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-sequence
|
|
PR:000036782 tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | hFASLG/iso:FasL/var:F273L |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | hFASLG/iso:FasL/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | hFASLG/iso:FasL/Clv:soluble |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000432 tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form | FASLG/iso:FasL/GlycoRes+ |
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000000546 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 | FASLG/iso:FasL/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | hFASLG/iso:FasL/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000547 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form | FASLG/iso:FasL/Clv:soluble |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | hFASLG/iso:FasL/Clv:soluble |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
sequence
|
|
PR:000000277 tumor necrosis factor ligand superfamily member 6 isoform FasLS | FASLG/iso:FasLS |
|
|
|
|
|
|
| | | | | | |
| | | |
organism-sequence
|
|
PR:P41047-2 tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) | mFASLG/iso:FasLS |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000018277 tumor necrosis factor ligand superfamily member 6 proteolytic cleavage product | FASLG/ClvPrd |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000547 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form | FASLG/iso:FasL/Clv:soluble |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036459 tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | hFASLG/iso:FasL/Clv:soluble |
Yes |
|
|
|